Texas Stock Exchange (TXSE) Selects Options’ AtlasInsight for Next Generation Packet Capture and Real Time Analytics March 11, 2026 Options Technology (Options), the leading provider of financial services infrastructure, today announced that its AtlasInsight platform has been selected by the Texas Stock Exchange (TXSE) to deliver high-fidelity packet capture and real-time analytics across TXSE’s proprietary, world-class trading infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260311267175/en/ As TXSE prepares to launch [...]
Xsolla Releases New Industry Report Identifying the Biggest Opportunities for the Future of Video Games for Developers March 11, 2026 The Xsolla Report Reveals How Studios Are Unlocking New Revenue, Reaching Global Audiences, and Building Durable Competitive Advantages
Cognitive Credit AI Sets New Standard for Tech-Enabled Credit Analysis March 11, 2026 Cognitive Credit, the leading provider of specialist data and analytics for corporate credit markets, today announces the launch of Cognitive Credit AI, a new intelligence capability integrated into its existing offering. The new service enables credit investors to generate detailed, context-aware analysis from a library of more than 200,000 official documents and structured financial data [...]
Janus Henderson Group plc Board of Directors Determines by Unanimous Vote that Victory Capital’s Proposal Is Not Superior and Reaffirms Recommendation of Transaction with Trian and General Catalyst March 11, 2026 Special Committee of Board and Its Advisors Reviewed Victory’s Non-Binding Unsolicited Proposal and Determines It Is Not in Best Interests of Janus Henderson and Its Shareholders Reaffirms Recommendation of Take-Private by Trian and General Catalyst Victory’s Proposal Not Actionable; Presents Significant Closing Risk and Uncertain Value
Curatis and Neupharma Announce Exclusive Licensing Agreement to Develop and Market Corticorelin (C-PTBE-01) for the Treatment of Peritumoral Brain Edema in Japan March 11, 2026 Japan is one of the world's most important pharmaceutical markets after the US and Europe. Neupharma’s team has extensive experience in developing and successfully commercialising orphan drugs as well as speciality care medicines in Japan, including a blockbuster drug. The agreement with Neupharma includes upfront and milestone payments of up to CHF 83.5 million as well as royalties of up to 20% on sales. The population of available patients eligible for corticorelin treatment associated with peritumoral brain edema is estimated at 60,000 in Japan and 500,000 worldwide. Global market potential is forecasted to exceed USD 1 billion annually.
FERM FOOD Acquires Orkla’s Former Site and Scales Up: Up to 20,000 Tonnes of Fermented Ingredients Per Year March 11, 2026 Danish ingredient producer FERM FOOD is acquiring Orkla’s former manufacturing site in Skovlund, Denmark, effective 1 April 2026. The acquisition provides new production facilities to expand the output of fermented plant-based ingredients for the food industry — driven by export demand that has emerged faster than expected. This press release features multimedia. View the full [...]
KBRA Assigns Preliminary Ratings to NewDay Partnership Master Trust, Series 2026-1 March 10, 2026 KBRA UK (KBRA) assigns preliminary ratings to three classes of notes to be issued under the NewDay Partnership Master Trust (Master Trust), a UK credit card ABS programme backed by receivables originated by NewDay Ltd. (NewDay) and serviced by NewDay Cards Ltd. NewDay is a UK-based consumer credit provider established in 2001 and regulated by [...]
Forbes 40th Annual World’s Billionaires List March 10, 2026 Elon Musk Is World’s Richest Person Ever Recorded
Language Weaver Brings Secure AI Translation Directly Into iManage Work Legal Workflows March 10, 2026 Secure multilingual content management gives legal firms competitive edge
Octus Unveils a Unified CreditAI Experience: The First-Ever, Compliance-Ready Generative AI Search for Both Public and Private Data Targeted Specifically for the Global Credit Markets March 10, 2026 New unified CreditAI is built on 12+ years of proprietary intelligence and data
